We went further to identify glioma-derived HMGB1 as the endogenous TLR2 ligand, whose signaling is necessary to elicit systemic adaptive immune-mediated GBM regression and long-term immunological memory in an intracranial glioma model (Figure 11) [51,66]. Here, HMGB1 is linked to central nervous system cancer.